Last refreshed: September 4, 2026 (US ET)
Back to holdings

ILMN

Growth

ILLUMINA INC

Health Care·Diagnostics & Research·β 1.47

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services.

Close · 3M

+57.09%

ILMN · 3M

+57.09%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 0 AI ETFs

None of the tracked AI ETFs currently hold this name.